Skip to content

PeNSAMI Phase 2: a multicenter Italian trial of home-based palliative care for people with severe multiple sclerosis and their carers

The Palliative Network for Severely Affected Adults with Multiple Sclerosis in Italy (PeNSAMI) Phase 2: a multicentre, phase II/III, single-blind, randomized controlled trial of home-based palliative care vs standard care for people with severe multiple sclerosis and their carers, and nested qualitative study

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN73082124
Enrollment
75
Registered
2014-06-19
Start date
2015-01-01
Completion date
Unknown
Last updated
2021-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis (MS) Nervous System Diseases Multiple sclerosis

Interventions

Study Intervention: At each center there will be a specially trained palliative care team (PCT) consisting of four professionals (physician, nurse, psychologist, and social worker). At

Sponsors

Foundation IRCCS Neurological Institute 'Carlo Besta' (Italy)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Subjects are eligible for recruitment if all of the following criteria are satisfied: 1. Definite MS (Polman 2011) 2. Age =18 years 3. Primary or secondary progressive MS course 4. EDSS = 8.0 5. Two or more unmet care needs from those identified in PeNSAMI Phase 1 (see above), or patient choice for comfort care only 6. One or more of the following patient clinical indicators (Thomas 2011): 6.1. Significant complex symptoms and medical complications 6.2. Dysphagia and poor nutritional status 6.3. Communication difficulties 6.4. Cognitive impairment, notably the onset of dementia 7. Presence of a carer (family member, relative, or friend, who is next of kin or is the key decision maker as designated by the [cognitively competent] patient and with whom the patient shares his/her life) 8. Signed informed consent (of both patient and carer)

Exclusion criteria

Exclusion criteria: 1. Hospitalized/institutionalized patients 2. Patients already receiving palliative care 3. Patient-carer dyads living out of the study area

Design outcomes

Primary

MeasureTime frame
Patient-related outcomes: 1. SEIQoL-DW - It was developed to assess quality of life from the individual's perspective (O'Boyle 1992). It is an interview-based instrument to assess the level of functioning in, and relative importance of, areas of life nominated by the respondent. The SEIQoL-DW index is obtained from the satisfaction and the weight of each elicited area, and can range from 0 (worst possible score) to 100 (best possible HRQoL score). 2. POS-S-MS - It comprises 18 items plus two open questions, using a 0-4 scale (Sleeman 2012). The psychometric properties of Core-POS (see below) and POS-S-MS have been assessed in patients severely affected by MS confirming that both are acceptable, reliable, and valid in this population (Sleeman 2012). An Italian version of POS-S-MS was devised for this study by the PeNSAMI lead centre. The score is the sum of the scores from each of the first 17 items, and therefore can range from 0 to 68.

Secondary

MeasureTime frame
Patient-related outcomes: 1. Core-POS - Self-assessed questionnaire on emotional, psychological and spiritual needs and provision of information and support [Hearn 1999; Higginson 2004]. It consists of 10 items, each scored from 0 (best) to 4 (worst). An additional question gives patients the opportunity to list their 'main problems'. The score is the sum of the scores from each of the 10 questions, and therefore can range from 0 to 40. 2. FIM - Care burden scale that consists of 13 physical (based on the Barthel Index) and 5 cognitive items [Hamilton 1987, Stineman 1997]. Each item is scored on the level of assistance required for an individual to perform activities of daily living from 1 (total dependence) to 7 (complete independence). The scale can be administered by a physician, nurse, therapist or lay person. Possible scores range from 18 to 126, with higher scores indicating more independence. 3. HADS - Self-assessed questionnaire consisting of 14 multiple choice (0-3 Likert scale) items probing symptoms of anxiety (7 items) and depression (7 items). HADS anxiety (HADS-A) and depression (HADS-D) scores range from 0 (no symptoms) to 21 (most severe symptoms) [Zigmond 1983]. Carer-related outcomes 1. SF-36 - Widely used self-reported generic measure of HRQoL consisting of 36 items in eight domains (physical function, social function, physical role limitations, emotional role limitations, pain, vitality, mental health, and general health) [Ware 1993, Apolone 1998]. Two composite scores (physical and mental) can be calculated. 2. HADS 3. EQ-5D - Most used generic preference-based measure of HRQoL which produces utility scores anchored at 0 (death) and 1 (perfect health) [Kind 1998; Johnson 1998]. EQ-5D utility scores represent preferences for particular health states. The descriptive system has five dimensions (mobility, self-care, usual activity, pain

Countries

Italy

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 17, 2026